Deutsche Bank’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
Deutsche Bank's AMAG Position: Q4 2020 in Review
Deutsche Bank sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 15,823 shares — an estimated $149K sold.
Deutsche Bank first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $13.7M in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Deutsche Bank reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Deutsche Bank sold 15,823 AMAG Pharmaceuticals shares in Q4 2020, an estimated $149K.
- Deutsche Bank first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Deutsche Bank's AMAG Pharmaceuticals position peaked at $13.7M in Q4 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Deutsche Bank's 13F filing for Q4 2020, filed 16 Feb 2021.